Meanwhile, Cees de Jong was elected vice chair, replacing Henrik Poulsen, while Britt Meelby Jensen and Stephan Engels were appointed as members of the board at the meeting on Friday.
Stocktwits·6d ago
More News
Toyota Commits Up To $10B Additional Investments In US Over Five Years
The company also kick-started production at its all-new $14 billion battery plant in Liberty, North Carolina, on Wednesday.
Stocktwits·8d ago
Novartis Opens New Manufacturing Facility In California In Bid To Increase US Presence
Commercial manufacturing at the facility is expected to begin once approval is granted by the U.S. Food and Drug Administration, the company added.
Stocktwits·10d ago
Stellantis NV Recalls Over 320,000 Jeep Plug-In Hybrids In US Over Fire Risk
The recall includes certain model year 2020- 2025 Jeep Wrangler 4Xe and model year 2022-2026 Grand Cherokee 4Xe plug-in hybrid vehicles.
Stocktwits·16d ago
Alibaba’s AI Glasses To Be Priced At $659, Pre-Sale Planned On October 24 Via Its E-commerce Platform Tmall: Report
Stocktwits·28d ago
AstraZeneca Unveils Expanded Facility In Texas Aimed At Doubling Production Of Hyperkalemia Drug
The facility in Coppell, which employs more than 250 people, is the sole global manufacturing facility for the company’s Lokelma.
Stocktwits·1mo ago
AstraZeneca Announces $4.5B Investment In Virginia
The investment is $500 million more than initially planned, intended to support the enhanced manufacturing capability of a broader range of medicines, according to the company.
Stocktwits·1mo ago
AstraZeneca Plans Ordinary Share Listing In US – Find Out More On The Harmonized Listing Structure
Michel Demaré, Chair of AstraZeneca, stated that enabling a global listing structure would allow the company to reach a broader mix of global investors and make it even more attractive to all its shareholders.
Stocktwits·2mo ago
US Regulator Closes Probe Into Stellantis’ 24,000 Alfa Romeo Giulia Vehicles
The U.S. auto safety regulator’s Office of Defects Investigation (ODI) had opened the probe in January 2024 to assess allegations of loss of motive power resulting from low-pressure fuel pump failures.
Stocktwits·2mo ago
US FDA Alleges Novo Nordisk’s Video On Weight-loss Drugs Featuring Oprah Winfrey Is ‘False Or Misleading’
The FDA alleged in a letter dated September 9 that the video misbranded Novo’s Wegovy, Ozempic, and Victoza, making its distribution violative.